Cognito Therapeutics is based in Cambridge. It has raised $93M in total funding. Latest round: Series B.
Cognito Therapeutics is based in Cambridge. Cognito Therapeutics has raised $93M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2023. The round record for Cognito Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include FoundersX Ventures, Alzheimer's Drug Discovery Foundation, Starbloom Capital, IAG Capital, WS Investment Company, Morningside. 6 distinct backers are named across the disclosed rounds.
Cognito Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026